Theriva Biologics Stock Surges 67.92% Post-Market

Theriva Biologics leads trending stocks with a massive 67.92% post-market soar. Investors watch the biotech closely after the sharp rally sparks buzz. Traders analyze catalysts behind the gain amid volatile markets. The spike draws attention to potential breakthroughs in the sector. Read more about this...